TBA Law Blog


Posted by: Azya Thornton on Apr 23, 2025

Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it illegally filled millions of invalid prescriptions for opioids and other controlled substances, the U.S. Justice Department said Monday. Under the agreement, the amount will be paid over six years with 4% annual interest, and the company will owe an additional $50 million if it is sold, merged or transferred before Fiscal Year 2032, Reuters reports. Prosecutors alleged Walgreens violated the Controlled Substances Act by ignoring “red flags” and filling unlawful prescriptions. The company said in a regulatory filing that it does not anticipate any major future opioid-related cases. Walgreens joins a number of other entities — drug manufacturers such as Purdue Pharma, Teva and Allergan, pharmacy operators such as Kroger, CVS, Walmart and Food Citymarketing firms and consulting firms — that have agreed to pay billions of dollars to resolve multiple lawsuits tied to the nation’s opioid epidemic.